Harrisburg, PA – According to filings with the U.S. Securities and Exchange Commission, MacuLogix is raising $8,500,114.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Bill Mcphee played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About MacuLogix

We’re on a mission to eliminate blindness caused by age-related macular degeneration (AMD). Our vision is bold but well within reach. MacuLogix is a company that equips eye care professionals with the technology, tools, and education needed to help identify and manage AMD patients early, before irreversible vision loss has occurred. We can help you deliver better patient care with the scientifically validated AdaptDx Pro. Help us save the eyesight of millions by making early functional testing for AMD a routine part of eye care for your aging patients.

To learn more about MacuLogix, visit http://www.maculogix.com/

Contact:
Bill Mcphee, Chief Executive Officer
717-914-4067
wmcphee@maculogix.com
https://www.linkedin.com/in/bill-mcphee-974b897/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved